Navigation Links
Gene Network Sciences Names Departing Merck Head of Genetics Eric Schadt as Co-Chair of Scientific Advisory Board
Date:4/7/2009

CAMBRIDGE, Mass., April 7 /PRNewswire/ -- Gene Network Sciences, Inc. today announced that it named Dr. Eric Schadt, a leading researcher in the field of genomics-driven drug discovery, co-chair of its Scientific Advisory Board.

Dr. Schadt will be leaving his position as Executive Scientific Director of Genetics at pharmaceutical giant Merck to join forces with the departing head of Merck oncology, Dr. Stephen Friend, to create Sage, an open-access distributed data platform designed to enable collaboration by integrating the myriad of genomic data sets in the public and private domains. At Merck's Rosetta subsidiary, Dr. Schadt founded the Genetics department. His work at Merck focused on elucidating the genetic circuitry of common human diseases such as type 2 diabetes and obesity using novel integrative genomics approaches based on genetic and molecular profiling data. He has helped define a new field in network biology -- the genetics of gene expression, or "integrative genomics." Dr. Schadt's pioneering work in integrative genomics has been published in a series of groundbreaking papers, culminating in two seminal Nature papers in 2008 that revealed the genetic circuitry underlying obesity and metabolic disease.

Dr. Schadt is also an Affiliate Professor in the Department of Biostatistics at the University of Washington in Seattle, and he was recently appointed as a Fellow in the Institute of Synthetic and Systems Biology at Imperial College London. Prior to joining Rosetta, Dr. Schadt was a Senior Research Scientist at Roche Bioscience. He received his B.S. in applied mathematics/computer science from California Polytechnic State University, his M.A. in pure mathematics from UCD, and his Ph.D. in bio-mathematics from UCLA.

"I am looking forward to the opportunity to assist GNS in their efforts to accelerate the medical impact that is starting to be reaped from the emerging field of integrative genomics," said Dr. Schadt. "Among biosimulation companies, GNS's REFS(TM) platform is the best available technology to turn integrative genomics data into actionable knowledge for drug discovery and development."

Dr. Schadt will join renowned computational biologist Dr. James Collins of Boston University to serve together as co-chairs of GNS's Scientific Advisory Board.

"We are pleased to welcome the world's leading expert on the application of integrative genomics in pharmaceutical drug discovery," said Colin Hill, CEO of GNS. "The addition of Dr. Schadt to our Scientific Advisory Board exemplifies GNS's commitment to bring together the best scientific minds and technology to use supercomputer-driven modeling and simulation approaches to transform drug discovery and development and bring breakthrough treatments to patients in need."

About Gene Network Sciences

Gene Network Sciences (http://www.gnsbiotech.com/) is a leader in biosimulation with its ability to derive molecular mechanisms of drugs and diseases directly from molecular profiling and clinical data. Based in Cambridge, Massachusetts, and Ithaca, New York, GNS uses its REFS(TM) technology in pharmaceutical and healthcare settings to rapidly turn combinations of genetic, genomic, and clinical measurements into models of disease progression and drug response. These models are then simulated to discover both new targets for drug intervention and genetic markers of drug response that allow patients who will respond to a given drug treatment to be matched to a particular clinical trial and treatment option. By discovering how and why specific sets of genes and drug candidates impact human biology, GNS technology enables the rapid development of breakthrough drug and diagnostic products and the matching of patients to the optimal therapy.


'/>"/>
SOURCE Gene Network Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Medtronic Foundation Awards Fourth Grant to the National Parkinson Foundations National Parkinson Care Network Program
2. Companion Benefit Alternatives Awarded Silver Honors for Best Practices in Health Plans and Health Networks by URAC
3. Harris Corporation Awarded Follow-on Contract Option to Expand CONNECT Solution for Nationwide Health Information Network
4. Social Security Administration First to Go Live With CONNECT Solution for Nationwide Health Information Network
5. Harris Corporation Awarded $14 Million Contract to Develop Multi-Hospital Military Health System Network with Image-Sharing Capabilities
6. CONNECT Solution for Nationwide Health Information Network Released For General Availability by U.S. Government
7. UltraRAD and StructuRad Add Valor Network, Inc. to Client Roster
8. Interactive Autism Network opens its doors to adults with autism
9. Innovation and Sharing of Client Successes Highlight GetWellNetworks GetConnected2009 Conference
10. If You Treated an Illinois Workers Compensation Patient or a Patient Covered by an Illinois Automobile Insurance Policy and Your Bill was Reduced by a Discount Pursuant to a First Health or CCN PPO Network, Please Read This Notice Carefully As It Affects
11. Golub Capital Provides Debt Financing to Support the Acquisition of Network Express, Inc., by Ace Expediters, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... New York, NY (PRWEB) , ... May 02, 2016 , ... ... Highlighting the year’s best in pet gear and toys, leading product review site ... TTPM Pets Paw of Excellence Awards at their Spring Showcase at the Metropolitan ...
(Date:5/2/2016)... NV (PRWEB) , ... May 02, 2016 , ... ... Pharmacy Times, has announced a new Specialty Pharmacy Patient Satisfaction Award that will ... based on the quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction ...
(Date:5/2/2016)... ... 2016 , ... According to an American Psychological Association article, the ... before the age of 18. Of those who survive, many still face effects as ... , In her new book, Lyah! Lyah! Pants on Fyah!, she shares stories from ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... ... Research & Analytics EVP and GM Jim Callandrillo and Duane Reed, VP ... 55th Annual Pharmaceutical Business Intelligence and Research Group (PBIRG) General Meeting ...
(Date:5/2/2016)... ... May 02, 2016 , ... The Evolve Paddle Board ... affordable prices announced today the outcome of their partnership with Yoloha Yoga- producers of ... “Roots Yoga Board.” , SUP yoga has seen a dramatic rise in popularity throughout ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... , April 29, 2016 /PRNewswire/ ... Contamine, Directeur Financier Sanofi, ... santé, publie ses résultats pour le ... du Groupe, Jérôme Contamine, commente les ... et les perspectives pour le reste ...
(Date:4/29/2016)... April 29, 2016 Automation is ... laboratory due to the growing demands for productivity in ... contemporary automated systems are already adept of a wide ... tedious and manual labor. Instrumentation continues to evolve, and ... conceivable just a few years ago. Originally used mostly ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s announced ... the company,s valve repair and stent business, healthcare ... places Abbott more firmly into patient monitoring.  Kalorama ... fastest growing device areas, with double-digit growth expected ... report,  Advanced Remote Patient Monitoring . ...
Breaking Medicine Technology: